Robin Stevenson
Direktor/Vorstandsmitglied bei Avelas Biosciences, Inc.
Aktive Positionen von Robin Stevenson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 18.10.2021 | - |
Karriereverlauf von Robin Stevenson
Ehemalige bekannte Positionen von Robin Stevenson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Breast Cancer Research Trust
 The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Neuseeland | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
Sektoral
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
The Breast Cancer Research Trust
The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Health Technology |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
- Börse
- Insiders
- Robin Stevenson
- Erfahrung
